Among these, TSC1 or TSC2 characterizes rare subependymal giant-cell astrocytomas in patients with tuberous sclerosis, causing aberrant activation of mTOR (47). This evidence concerns the gene TSC2 and astrocytoma (excluding glioblastoma).